Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 3826 participants.

Also called NCT07349875

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 3,826 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07349875
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07349875. Randomized; single masking; primary purpose treatment. Start 2026-01-01 (actual); primary completion 2029-12-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial
Acronym
COLOR
Intervention (Drug)
Colchicine combined with Guideline-Directed Medical Therapy
Lead sponsor
Nanjing First Hospital, Nanjing Medical University (class: other)

Record details

Record id
cardio:ct-nct07349875
Content hash
465fd306cb4b48bee339903f833cbd13ff189917a606f72e33ea04ff83f38193